Komori
Miahelsa Holdings (7129) · RiskMaterialised

Stagnating performance at a new pharmacy due to delays in establishing patient intake arrangements at a newly opened large hospital

First written in FY2023-Q2. 1 of 1 entries say "Materialised", first in FY2023-Q2. Latest entry: FY2023-Q2.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Stagnant performance at new pharmacies due to delays in patient intake at newly opened hospitalsA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2023-Q2MaterialisedAnnual report

    「In addition to the impact of delays in preparing the newly built large hospital that serves as the source of prescriptions to accept patients, the new pharmacies incurred upfront costs for their openings, resulting in sluggish sales and profit performance.」

    Delays in preparing the newly built large hospital to accept patients and upfront costs for opening pharmacies actually resulted in sluggish sales and profit growth.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Miahelsa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Stagnating performance at a new pharmacy due to delays in establishing patient intake arrangements at a newly opened large hospital | Miahelsa Holdings Corporation (7129) | Komori